Marc R. Larochelle, MD, MPH

Assistant Professor, Medicine

Marc Larochelle
801 Massachusetts Ave Crosstown Center

Biography

Marc Larochelle is a general internist and clinical investigator specializing in addiction medicine at BMC and an assistant professor of medicine at BUSM. Larochelle’s clinical and research interests focus on the safety of opioid prescribing and the recognition and treatment of opioid use disorders. As a health services researcher, Larochelle aims to leverage insights from large data sources and translate the findings into interventions that improve the quality and value of health care delivered. His special interests are Primary Care and Addiction Medicine.

Other Positions

  • Faculty, Clinical Addiction Research and Education Unit, Medicine, Boston University School of Medicine

Education

  • University of Pittsburgh School of Medicine, MD
  • Harvard School of Public Health, MPH
  • Duke University, BSE

Publications

  • Published on 11/2/2021

    Kimmel SD, Kim JH, Kalesan B, Samet JH, Walley AY, Larochelle MR. Against Medical Advice Discharges in Injection and Non-injection Drug Use-associated Infective Endocarditis: A Nationwide Cohort Study. Clin Infect Dis. 2021 11 02; 73(9):e2484-e2492. PMID: 32756935.

    Read at: PubMed
  • Published on 9/9/2021

    Larochelle MR, Slavova S, Root ED, Feaster DJ, Ward PJ, Selk SC, Knott C, Villani J, Samet JH. Disparities in Opioid Overdose Death Trends by Race/Ethnicity, 2018-2019, From the HEALing Communities Study. Am J Public Health. 2021 10; 111(10):1851-1854. PMID: 34499540.

    Read at: PubMed
  • Published on 8/28/2021

    Root ED, Slavova S, LaRochelle M, Feaster DJ, Villani J, Defiore-Hyrmer J, El-Bassel N, Ergas R, Gelberg K, Jackson R, Manchester K, Parikh M, Rock P, Walsh SL. The impact of the national stay-at-home order on emergency department visits for suspected opioid overdose during the first wave of the COVID-19 pandemic. Drug Alcohol Depend. 2021 Aug 28; 228:108977. PMID: 34598100.

    Read at: PubMed
  • Published on 8/17/2021

    Larochelle MR, Cruz R, Kosakowski S, Gourlay DL, Alford DP, Xuan Z, Krebs EE, Yan S, Lasser KE, Samet JH, Liebschutz JM. Do Urine Drug Tests Reveal Substance Misuse Among Patients Prescribed Opioids for Chronic Pain? J Gen Intern Med. 2021 Aug 17. PMID: 34405344.

    Read at: PubMed
  • Published on 8/12/2021

    Shanahan CW, Reding O, Holmdahl I, Keosaian J, Xuan Z, McAneny D, Larochelle M, Liebschutz J. Opioid analgesic use after ambulatory surgery: a descriptive prospective cohort study of factors associated with quantities prescribed and consumed. BMJ Open. 2021 08 12; 11(8):e047928. PMID: 34385249.

    Read at: PubMed
  • Published on 8/3/2021

    Larochelle M, Lagisetty PA, Bohnert ASB. Opioid Tapering Practices-Time for Reconsideration? JAMA. 2021 08 03; 326(5):388-389. PMID: 34342635.

    Read at: PubMed
  • Published on 6/23/2021

    Alrawashdeh M, Klompas M, Kimmel S, Larochelle MR, Gokhale RH, Dantes RB, Hoots B, Hatfield KM, Reddy SC, Fiore AE, Septimus EJ, Kadri SS, Poland R, Sands K, Rhee C. Epidemiology, Outcomes, and Trends of Patients With Sepsis and Opioid-Related Hospitalizations in U.S. Hospitals. Crit Care Med. 2021 Jun 23. PMID: 34314131.

    Read at: PubMed
  • Published on 6/17/2021

    Morgan JR, Quinn EK, Chaisson CE, Ciemins E, Stempniewicz N, White LF, Larochelle MR. Potential barriers to filling buprenorphine and naltrexone prescriptions among a retrospective cohort of individuals with opioid use disorder. J Subst Abuse Treat. 2021 Jun 17; 108540. PMID: 34148756.

    Read at: PubMed
  • Published on 5/10/2021

    Kimmel SD, Anderson ES, Larochelle MR. HIV testing among people with and without substance use disorder in emergency departments: A nationwide cohort study. Am J Emerg Med. 2021 10; 48:269-272. PMID: 34015610.

    Read at: PubMed
  • Published on 4/1/2021

    Kerensky T, LaRochelle M, Fan SL, Kosakowski S, Wason K, Walley AY. Non-prescription Fentanyl Positive Toxicology: Prevalence, Positive Predictive Value of Fentanyl Immunoassay Screening, and Description of Co-substance Use. J Addict Med. 2021 04 01; 15(2):150-154. PMID: 32909981.

    Read at: PubMed

View 60 more publications: View full profile at BUMC

View all profiles